Investigational drug · Phase 3
BHB-1893
Not approved by FDA. In 2 industry-sponsored Phase 2 or 3 trials that are active or finished in the last two years, most often for Cardiomyopathy, Hypertrophic Non-Obstructive, Cardiomyopathy, Hypertrophic Obstructive.
Phase 3Last checked: Nov 19, 2026Latest source record: Nov 18, 2026 (newest trial update)Source: ClinicalTrials.govMethods & limitations
Highest phase
Phase 3
Industry-sponsored trials
Phase 2 and 3 trials
2
2 still active
All registered trials
2
Any phase or sponsor naming "BHB-1893"
First trial start
2026
Sep 2, 2026
Sponsors
Lead sponsors of its Phase 2 and 3 trials.
All registered trials by phase
Every ClinicalTrials.gov drug study naming "BHB-1893", any sponsor or status.
Conditions studied
As listed on its trial records.
- Cardiomyopathy, Hypertrophic Non-Obstructive
- Cardiomyopathy, Hypertrophic Obstructive
Approved drugs for the same conditions: Cardiovascular and metabolic
Largest trials
Live from ClinicalTrials.gov: studies naming "BHB-1893" as an intervention, largest first.
- BHB-1893 vs. Placebo for Symptomatic Non-obstructive Hypertrophic CardiomyopathyPivotal-lookingNot yet recruiting
Braveheart Bio, Inc.Industry
NCT07946107 · 600 participants (planned) · Start Dec 2026 · Primary completion Dec 2029
Drug: BHB-1893 · For: Cardiomyopathy, Hypertrophic Non-Obstructive
- BHB-1893 Versus Metoprolol for Symptomatic Obstructive Hypertrophic CardiomyopathyPivotal-lookingRecruiting
Braveheart Bio, Inc.Industry
NCT07755904 · 210 participants (planned) · Start Sep 2, 2026 · Primary completion Oct 2028
Drug: BHB-1893; Metoprolol · For: Cardiomyopathy, Hypertrophic Obstructive
Sites: Burlington, Massachusetts; Manhasset, New York; Rock Hill, South Carolina · 4 sites in all
Newest research
PubMed records naming it or its code names, newest first.
No PubMed records name it yet, which is common for early code-named drugs.
Names are merged from how sponsors list this drug on ClinicalTrials.gov, so an alias can occasionally belong to a related compound. Development status changes faster than registry records do.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.